[Duspatalin in functional disorders of the Oddi's sphincter in patients subjected cholecystectomy]. 2002

A A Il'chenko, and E V Bystrovskaia
Central Scientific Research Institute of Gastroenterology, Moscow.

There was an examination of 20 patients who had cholecystectomy and have dysfunctional disorders of the Oddi's sphincter. All of the patients underwent the monotherapy with Mebeverine Retard in the dosage of 200 mg twice a day. The treatment efficiency was evaluated by the dynamics of clinical symptoms, results of the study of biochemical blood indices, data of the ultrasonic examination, and intragastric pH measurement. A positive dynamics was observed against the background of the preparation administration, and it became apparent from the disappearance or reduction of pains strength, dyspeptic manifestations, normalization or improvement of biochemical blood indices, and reduction of the common bile duct lumen width according to the ultrasonic examination data.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009803 Sphincter of Oddi The sphincter of the hepatopancreatic ampulla within the duodenal papilla. The COMMON BILE DUCT and main pancreatic duct pass through this sphincter. Oddi's Sphincter,Oddi Sphincter,Oddis Sphincter,Sphincter, Oddi's
D010276 Parasympatholytics Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. Antispasmodic,Antispasmodic Agent,Antispasmodic Drug,Antispasmodics,Parasympathetic-Blocking Agent,Parasympathetic-Blocking Agents,Parasympatholytic,Parasympatholytic Agent,Parasympatholytic Drug,Spasmolytic,Spasmolytics,Antispasmodic Agents,Antispasmodic Drugs,Antispasmodic Effect,Antispasmodic Effects,Parasympatholytic Agents,Parasympatholytic Drugs,Parasympatholytic Effect,Parasympatholytic Effects,Agent, Antispasmodic,Agent, Parasympathetic-Blocking,Agent, Parasympatholytic,Agents, Antispasmodic,Agents, Parasympathetic-Blocking,Agents, Parasympatholytic,Drug, Antispasmodic,Drug, Parasympatholytic,Drugs, Antispasmodic,Drugs, Parasympatholytic,Effect, Antispasmodic,Effect, Parasympatholytic,Effects, Antispasmodic,Effects, Parasympatholytic,Parasympathetic Blocking Agent,Parasympathetic Blocking Agents
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D002763 Cholecystectomy Surgical removal of the GALLBLADDER. Cholecystectomies
D002769 Cholelithiasis Presence or formation of GALLSTONES in the BILIARY TRACT, usually in the gallbladder (CHOLECYSTOLITHIASIS) or the common bile duct (CHOLEDOCHOLITHIASIS). Gallstone Disease,Cholelithiases,Gallstone Diseases
D003137 Common Bile Duct Diseases Diseases of the COMMON BILE DUCT including the AMPULLA OF VATER and the SPHINCTER OF ODDI.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A A Il'chenko, and E V Bystrovskaia
January 1988, Acta gastro-enterologica Belgica,
A A Il'chenko, and E V Bystrovskaia
October 1988, Klinicheskaia meditsina,
A A Il'chenko, and E V Bystrovskaia
January 1989, Acta medica portuguesa,
A A Il'chenko, and E V Bystrovskaia
October 1958, Revista espanola de las enfermedades del aparato digestivo y de la nutricion,
A A Il'chenko, and E V Bystrovskaia
September 1989, Revista medica de Chile,
A A Il'chenko, and E V Bystrovskaia
June 1950, Boletines y trabajos de la Academia Argentina de Cirugia. Academia Argentina de Cirugia,
A A Il'chenko, and E V Bystrovskaia
May 1980, Gastroenterologie clinique et biologique,
A A Il'chenko, and E V Bystrovskaia
January 1981, Medecine & chirurgie digestives,
A A Il'chenko, and E V Bystrovskaia
February 1979, Gastroenterologie clinique et biologique,
Copied contents to your clipboard!